Keyphrases
Late Xerostomia
100%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
100%
PET Image
100%
Digital Biomarkers
100%
Biomarker Model
60%
Head-and-neck Cancer
55%
Xerostomia
53%
Cancer Radiotherapy
50%
Salivary Gland
50%
Recurrence-free Survival Prediction
50%
Prediction Model
50%
Imaging Biomarkers
50%
Parotid Gland
47%
Validation Cohort
45%
Submandibular Gland
35%
PET Imaging
30%
Composite Model
20%
Area under the Curve
17%
Performance Prediction
15%
Moderate to Severe
14%
90th Percentile
14%
Standardized Uptake Value
14%
Calibration Plot
14%
Parotid Gland Dose
14%
Training Population
10%
Radiotherapy
7%
Patient-rated
7%
Treatment Risk
7%
Risk Factors
7%
Model Discrimination
7%
Individualized Information
7%
Improved Prediction
7%
Mean Model
7%
Model Performance
5%
Prediction Approach
5%
Bootstrap
5%
Potential Improvement
5%
Individualized Prediction
5%
Cancer Patients
5%
Forward Selection
5%
Mean Dose
5%
Likelihood Ratio Test
5%
Total Energy
5%
Medicine and Dentistry
Biological Marker
68%
Oropharyngeal Cancer
50%
Positron Emission Tomography-Computed Tomography
50%
Head and Neck Cancer
50%
Neoplasm
50%
Radiomics
50%
Recurrence Free Survival
50%
Xerostomia
50%
Fluorodeoxyglucose F 18
50%
Survival Prediction
50%
Cancer Radiotherapy
50%
Positron Emission Tomography
50%
Cross-Validation
18%
Clinical Feature
18%
Base
16%
Computer Assisted Tomography
12%
Parotid Gland
12%
Contralateral
12%
Standardized Uptake Value
8%
Proportional Hazards Model
6%
Lymph Node
6%
Primary Tumor
6%
Oropharynx Squamous Cell Carcinoma
6%
